The validity of explicit indicators of prescribing appropriateness

International Journal for Quality in Health Care

Volumn 18, Issue 2, 2006, Pages 87-94

  Tully, Mary Patricia ^a   Cantrill, Judith A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Appropriateness; Indicators; Prescribing; Validity assessment

Indexed keywords

AMIODARONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LAXATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PHENYTOIN; RABEPRAZOLE;

CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG POTENTIATION; EVIDENCE BASED PRACTICE; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL PHYSICIAN; HUMAN; INTERVIEW; IRON DEFICIENCY ANEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MEDICAL PRACTICE; MEDICAL RECORD; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITATIVE ANALYSIS; REVIEW; RISK BENEFIT ANALYSIS; THYROID DISEASE; UNITED KINGDOM; VALIDATION PROCESS;

ATTITUDE OF HEALTH PERSONNEL; CONSENSUS; DRUG UTILIZATION REVIEW; GREAT BRITAIN; HOSPITALS, PUBLIC; HOSPITALS, TEACHING; HUMANS; INTERVIEWS; MEDICAL STAFF, HOSPITAL; PHARMACOPOEIAS; PHARMACY SERVICE, HOSPITAL; PRESCRIPTIONS, DRUG; QUALITY INDICATORS, HEALTH CARE;

EID: 33645541513     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzi084     Document Type: Review

References (29)

1. Australian Council for Safety and Quality in Health Care. Patient Safety: Towards Sustainable Improvement. Fourth Report to the Australian Health Ministers' Conference. Canberra: Australian Council for Safety and Quality in Health Care, 2003.
2. The President's Advisory Commission on Consumer Protection and Quality in the Health Care Industry. Quality First: Better Health Care for All Americans. Washington, DC: US Government Printing Office, 1998.
3. Department of Health. A First Class Service. Quality in the New NHS. London: Department of Health, 1998.
4. Department of Health. Building a Safer NHS for Patients - Improving Medication Safety. London: The Stationery Office, 2004.
5. Buetow SA, Sibbald B, Cantrill JA, Halliwell S. Appropriateness in health care: Application to prescribing. Soc Sci Med 1997; 45: 261-271.
6. Oborne CA, Hooper R, Li KC, Swift CG, Jackson SHD. An indicator of appropriate neuroleptic prescribing in nursing homes. Age Ageing 2002; 31 (6): 435-439.
7. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825-1832.
8. Nirodi P, Mitchell A. The quality of psychotropic drug prescribing in patients in psychiatric units for the elderly. Aging Ment Health 2002; 6 (2): 191-196.
9. Lindley CM, Tully MP, Parmasothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294-300.
10. Medical Economics. Physician's Desk Reference, fifty-eighth edition. Montvale, NJ: Medical Economics Co. Inc., 2004.
11. Joint Formulary Committee. British National Formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2005.
12. Hanlon JT, Schmader KE, Samsa GP et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045-1051.
13. Cantrill JA, Sibbald B, Buetow S. Indicators of the appropriateness of long term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility and reliability. Qual Health Care 1998; 7: 130-135.
14. Tully MP, Javed N, Cantrill JA. Development and face validity of explicit indicators of the appropriateness of long-term prescribing. Pharm World Sci in press.
15. Tully MP, Cantrill JA. The reliability of explicit indicators of appropriateness of long term prescribing. Pharm World Sci in press.
16. Tully MP, Cantrill JA. Exploring the domains of appropriateness of drug therapy, using the Nominal Group Technique. Pharm World Sci 2002; 24: 128-131.
17. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In Bryman A, ed. Analysing Qualitative Data. London: Routledge, 1994: 173-194.
18. Britten N, Jenkins L, Barber N, Bradley C, Stevenson F. Developing a measure for the appropriateness of prescribing in general practice. Qual Saf Health Care 2003; 12: 246-250.
19. Sharpe VA, Faden AI. Appropriateness in patient care: A new conceptual framework. Milbank Q 1996; 74: 115-138.
20. Volume CI, Burback LM, Farris KB. Re-assessing the MAI: Elderly people's opinions about medication appropriateness. Int J Pharm Pract 1999; 7: 129-137.
21. Audit Commission. Setting the Record Straight. A Review of Progress in Health Records Services. London: Audit Commission Publications, 1999.
22. Aronson JK. Rational prescribing, appropriate prescribing. Br J Clin Pharmacol 2004; 57 (3): 229-230.
23. Berg M. Medical work and the computer-based patient record: A sociological perspective. Methods Inf Med 1998; 37: 294-301.
24. Tully MP, Cantrill JA. Insights into creation and use of prescribing documentation in the hospital medical record. J Eval Clin Pract 2005; 11: 430-435.
25. Hope C, Overhage JM, Seger A et al. A tiered approach is more cost effective than traditional pharmacist-based review for classifying computer-detected signals as adverse drug events. J Biomed Inform 2003; 36: 92-98.
26. Berg M. Patient care information systems and health care work: A sociotechnical approach. Int J Med Inf 1999; 55: 87-101.
27. Park RE, Fink A, Brook RH et al. Physician ratings of appropriate indications for six medical and surgical procedures. Am J Public Health 1986; 76: 766-772.
28. Freeman AC, Sweeney K. Why general practitioners do not implement evidence: Qualitative study. Br Med J 2001; 323 (7321): 1100-1102.
29. British Medical Association. Doctors' Training and Qualifications: http://www.bma.org.uk/ap.nsf/Content/doctorsqual Accessed 21 May 2004.